Bio-Techne SVP exercises options, withholds shares
Bio-Techne Corp SVP and General Counsel Shane Bohnen exercised stock options for 448 shares of common stock on 2026-07-23 at an exercise price of 47.6000 per share, converting an option on 448 shares into directly held stock.
Rhea-AI Filing Summary
Bio-Techne Corp SVP and General Counsel Shane Bohnen exercised stock options for 448 shares of common stock on 2026-07-23 at an exercise price of 47.6000 per share, converting an option on 448 shares into directly held stock. To satisfy the exercise price or related tax obligations, 344 shares of common stock were withheld at 71.7700 per share. He continues to hold multiple option and stock-unit awards, including stock options over 8,944 shares at a 66.9700 exercise price expiring 2027-08-05 and 3,460 shares at 120.4600 expiring 2028-08-06. The filing indicates these transactions were not made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
448 shares exercised/converted
Exercise
17 txns
Insider
Bohnen Shane
Role
SVP - General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1 | 448 | $0.00 | $0.00 |
| Exercise | Common Stock | 448 | $47.60 | $21K |
| Exercise Price or Tax Liability | Common Stock | 344 | $71.77 | $25K |
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F5 | -- | -- | -- |
| holding | Restricted Stock Units F4, F6 | -- | -- | -- |
| holding | Performance Restricted Stock Units F4, F7 | -- | -- | -- |
| holding | Performance Stock Option (Right to Buy) F7 | -- | -- | -- |
| holding | Performance Restricted Stock Units F4, F8 | -- | -- | -- |
| holding | Restricted Stock Units F4, F9 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F10 | -- | -- | -- |
| holding | Performance Restricted Stock Units F4, F11 | -- | -- | -- |
| holding | Restricted Stock Units F4, F12 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F13 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 67,527 contracts (Direct);
Common Stock — 7,353 shares (Direct);
Restricted Stock Units — 10,383 contracts (Direct);
Performance Restricted Stock Units — 28,806 contracts (Direct);
Performance Stock Option (Right to Buy) — 12,924 contracts (Direct)
Footnotes (13)
- F1. Fully exercisable.
- F2. Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024.
- F3. Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027.
- F4. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F5. Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.
- F6. 49 restricted stock units vest on 8/15/2026.
- F7. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F8. Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F9. 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
- F10. Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
- F11. Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F12. 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
- F13. Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028.
Key Figures
Options exercised into common stock: 448.0000 shares
Exercise price for options exercised: 47.6000 per share
Shares withheld for taxes or exercise price: 344.0000 shares
+5 more
8 metrics
Options exercised into common stock
448.0000 shares
Stock options for common stock exercised at 47.6000 per share on 2026-07-23
Exercise price for options exercised
47.6000 per share
Exercise price for 448.0000 stock options converted into common stock
Shares withheld for taxes or exercise price
344.0000 shares
Common shares withheld at 71.7700 per share to pay exercise price or tax liability
Withholding price per share
71.7700 per share
Price used for withholding 344.0000 shares coded as tax or exercise-price payment
Option position expiring 2027-08-05
8944.0000 shares
Underlying shares for a stock option with a 66.9700 exercise price expiring 2027-08-05
Option position expiring 2028-08-06
3460.0000 shares
Underlying shares for a stock option with a 120.4600 exercise price expiring 2028-08-06
Performance stock option underlying shares
12924.0000 shares
Underlying common shares for Performance Stock Option (Right to Buy) at 84.6100 exercise price
Performance restricted stock units outstanding
4802.0000 shares
Underlying common shares for Performance Restricted Stock Units held directly
Key Terms
Stock Option (Right to Buy), Restricted Stock Units, Performance Restricted Stock Units, Performance Stock Option (Right to Buy), +1 more
5 terms
Stock Option (Right to Buy) financial
"Security title listed as Stock Option (Right to Buy) for derivative entries"
Restricted Stock Units financial
"Security title reported as Restricted Stock Units with common stock underlying"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance Restricted Stock Units financial
"Security title shown as Performance Restricted Stock Units with vesting on performance goals"
Performance restricted stock units (PRSUs) are promises to deliver company shares to employees or executives only if the business meets specific performance targets and any time-based holding rules. Think of them as a bonus that converts into stock only after set goals are reached, so investors watch PRSUs for two reasons: they can dilute existing shares if paid out, and they signal how closely management’s pay is tied to company performance.
Performance Stock Option (Right to Buy) financial
"Derivative security titled Performance Stock Option (Right to Buy) with 12,924 underlying shares"
Payment of exercise price or tax liability by delivering or withholding securities financial
"Transaction code F described as payment of exercise price or tax liability"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Bio-Techne (TECH) report for Shane Bohnen?
Bio-Techne reported that SVP and General Counsel Shane Bohnen exercised stock options for 448 shares of common stock at 47.6000 per share on 2026-07-23, with an associated option on 448 shares removed from his derivative holdings and 344 shares withheld to cover exercise price or taxes.
What option and stock-unit awards does Shane Bohnen still hold at Bio-Techne (TECH)?
Shane Bohnen continues to hold several equity awards, including stock options over 8,944 underlying shares at a 66.9700 exercise price expiring 2027-08-05 and options over 3,460 underlying shares at 120.4600 expiring 2028-08-06, along with multiple restricted and performance stock units.
Were Shane Bohnen’s Bio-Techne (TECH) transactions made under a Rule 10b5-1 plan?
The Form 4 indicates these transactions were not made under a Rule 10b5-1 trading plan, as the filing’s Rule 10b5-1 checkbox is not marked. No footnote describes any pre-arranged trading arrangement governing this option exercise or the related share withholding.
AI-generated analysis. How Rhea-AI works. Not financial advice.
